While Wall Street whispers the word “bear market,” the cash registers are ringing in Europe. In the very week that the S&P 500 stretched its June loss to roughly three percent and the Nasdaq fell for a fourth straight session, J.P. Morgan lifted its year-end target for Europe’s benchmark Stoxx Europe 600 sharply — to 680 points, up from 630. That is more than a tweak to a spreadsheet. It may be the clearest signal yet that the “great rotation” everyone has been talking about has a second, far more consequential dimension. Money is not merely leaving expensive technology shares for defensive sectors. It is crossing the Atlantic, flowing out of America and into Europe.
What J.P. Morgan actually said
J.P. Morgan’s strategists raised their December 2026 target for the Stoxx 600 from 630 to 680 points. With the index trading near 636, that implies roughly seven percent of additional upside by year-end — and that comes after the benchmark already printed a fresh all-time high this week. The bank also nudged up its target for America’s S&P 500, from 7,600 to 7,800, but the message between the lines is unmistakable: on a relative basis, the analysts now see the better risk-reward in Europe.
J.P. Morgan is not a lone voice. Goldman Sachs set its Stoxx 600 target at 660 in early June, and UBS is working with 650. That means three of the most influential investment banks in the world have raised their expectations for European equities within a matter of weeks. When the big houses turn more constructive in lockstep, it is rarely a coincidence — it reflects a shift in positioning that is already under way in institutional portfolios.
The transatlantic about-turn
To understand why Europe is suddenly in demand again, look at the two central banks, because that is where the decisive fault line runs. In the United States, the Federal Reserve under Kevin Warsh has edged closer to another rate hike than to a cut, after the Fed’s preferred inflation gauge, the PCE index, climbed above four percent in May. Rising rates are poison for richly valued growth stocks whose profits lie far in the future — and the American market is full of exactly those.
In Europe the picture is reversed. Many market participants now regard the European Central Bank as effectively finished with its tightening cycle; further hikes are increasingly being priced out. It was precisely that prospect that helped drive the Stoxx 600 to its record this week, as investors concluded the ECB’s foot was coming off the brake. One central bank easing off while the other threatens to press down again is exactly the kind of divergence that redirects global capital flows. On top of that, geopolitical tension around Iran has eased following an agreement reached in mid-June. The risk premium European equities have carried for years, owing to their proximity to the region’s flashpoints, is shrinking.
The numbers behind the optimism
Optimism alone does not move a price — in the end, earnings do. Here too J.P. Morgan offers hard arguments. The bank raised its forecast for eurozone corporate earnings growth in 2026 from 13 to 18 percent, and now expects twelve percent in 2027, up from ten. The most striking revision concerns the United Kingdom: there the analysts lifted their 2026 earnings-growth estimate from eight percent to a remarkable 18 percent — more than a doubling.
Behind that brightening lies a paradox. The worldwide investment boom around artificial intelligence, currently feared on Wall Street as a cost risk, is increasingly showing up in Europe as an opportunity. European companies are either building the physical backbone of the wave — semiconductor equipment, power grids, cooling, industrial automation — or benefiting through productivity gains. While America’s hyperscalers burn through hundreds of billions of dollars and markets fret over shrinking free cash flow, European suppliers are simply selling the shovels for the gold rush.
Then there is the simple but powerful factor of valuation. European shares have traded at a meaningful discount to the American market for years. As long as growth was missing, that discount was justified. But now, with earnings forecasts accelerating just as the expensive US names wobble, the discount turns from a flaw into a reason to buy. That combination — cheap valuation meeting rising profits — is the stuff multi-year upswings are made of.
A record-hunt across Europe’s exchanges
Price action has long since proved the strategists right. The Stoxx 600 closed this week at a fresh all-time high, gaining 0.8 percent on Friday. Germany’s DAX, which has cleared the 25,000-point mark, advanced 1.03 percent; France’s CAC 40 rose 0.55 percent; and Britain’s FTSE 100 — which had already topped the 10,000 threshold for the first time earlier in 2026 — added 0.65 percent. The Euro Stoxx 50, which bundles the fifty largest eurozone companies, is trading near its record of around 5,850 points.
This strength is no flash in the pan. 2025 was already an exceptional year: the Stoxx 600 gained roughly 17 percent and the Euro Stoxx 50 about 18 percent — the best year for European equities since 2021. That rally was driven by falling interest rates, Germany’s fiscal package and an early rotation out of richly valued US technology stocks. What is playing out now is the continuation of that story under sharper conditions — this time with the tailwind of three big-bank upgrades at once.
Why the flows are following the call
There is a mechanical dimension to this rotation that is easy to overlook. For more than a decade, global fund managers have been structurally overweight the United States, for the simple reason that American mega-caps delivered the returns. That positioning has become extraordinarily crowded: by many measures, the largest handful of US technology names came to represent an unprecedented share of global equity benchmarks. When such a concentrated trade begins to wobble, even a modest decision to trim it releases an enormous pool of capital that has to find a new home. Europe, cheap and under-owned, is the natural destination.
Surveys of fund-manager positioning have for months shown the lowest enthusiasm for US equities in years alongside a steady rebuilding of European exposure. That is the quiet engine beneath the headline price targets: it is not that a single bank note moves a continent, but that the note crystallises and accelerates a reallocation that thousands of allocators were already contemplating. When the flow and the narrative point the same way, trends tend to feed on themselves — which is precisely why momentum-driven moves can run further, and reverse faster, than fundamentals alone would justify.
Which European stocks stand to benefit
For investors, the compelling question is who specifically wins from this rotation. Britain’s FTSE 100, long dismissed as a value backwater, suddenly looks like a destination rather than a trap: heavyweight defensives such as pharma giant AstraZeneca, energy majors like Shell, and globally diversified consumer franchises give the index exactly the qualities a cautious-but-constructive market wants. Across the continent, the European champions that carry weight in any broad Stoxx 600 or MSCI Europe portfolio stand out: the Dutch chip-equipment maker ASML, an indispensable link in global semiconductor production; Danish pharma giant Novo Nordisk; French luxury group LVMH; German industrial bellwether Siemens; and the banks, which benefit from steeper yield curves and resilient credit demand.
A distinctive sub-theme is defence. Europe’s rearmament drive has turned names such as Germany’s Rheinmetall and France’s Thales into some of the strongest multi-year performers on the continent — a structural shift in government spending that is largely insulated from the AI-capex anxieties haunting US tech. Investors who would rather not pick individual names can capture the whole spectrum most easily through a low-cost ETF tracking the Stoxx Europe 600 or the MSCI Europe — broad, liquid, and carrying precisely the valuation discount the banks now cite as a reason to buy.
Risks and counterarguments
As compelling as the thesis sounds, it is not a sure thing. The biggest risk is transatlantic contagion. Should Wall Street not merely correct but tip into a genuine sell-off, no European market would be able to decouple. Correlations in stress phases run close to one; “decoupling” works better in theory than in a panic. To bet on Europe is implicitly to bet that US weakness stays a healthy rotation rather than escalating into a global risk-off shock.
Second, there is the currency. A strengthening euro — whether because Fed rate expectations flip again or capital pours into the eurozone — erodes the profits of the many export-heavy European companies that earn a large share of their revenue in dollars. What helps the index through inflows can hurt it through earnings. Third, the profit forecasts are ambitious: 18 percent growth for both the eurozone and the UK is no foregone conclusion, and any disappointment in the reporting season would immediately call the valuation re-rating into question. And fourth, geopolitics remains fragile — the Iran agreement lowered the risk premium, but a relapse into old tensions could bring it back just as quickly.
What it means for investors
For long-term investors the conclusion is sober but clear: diversifying across the Atlantic is no longer a box-ticking exercise in 2026; it is gradually becoming a source of return. Anyone who has run a heavily US-weighted portfolio in recent years — because that is where the music was playing — should at least check whether a structural overweight to America still fits a changed landscape. A broad Europe ETF can defuse that concentration risk without requiring any market timing.
It is worth remembering that bank price targets are snapshots, not guarantees. A target of 680 is an expectation, not a promise, and three houses agreeing does not make them right — it makes the trade crowded, which itself is a risk. This article is market commentary and educational context, not investment advice. Tax treatment of foreign dividends and capital gains varies widely by country of residence, and readers should weigh withholding taxes and their own circumstances before acting. The signal worth taking away is not a specific number on a screen, but a regime change in how the world’s largest banks are allocating risk.
Outlook
The coming days bring the next reality check. In the United States, consumer confidence, the JOLTS labour-market data and quarterly results from heavyweights such as Nike will keep stoking the Fed’s rate debate. The more hawkish that picture, the more attractive the European alternative looks on a relative basis. If the reporting season on the continent confirms the high earnings expectations, the rotation into Europe will have its strongest argument: not hope, but substance. Should the fear instead prove correct — that US weakness is the beginning of something larger — Europe would not escape unscathed either. But one thing this week made unmistakably clear: the old continent is back in the conversation, and Wall Street’s biggest houses are putting money on it.
Try TradingView Free for 30 Days
Plus get a $15 discount on your first subscription through this link.
